trending Market Intelligence /marketintelligence/en/news-insights/trending/IdPL9HRMh4TYTsgZye-iag2 content esgSubNav
In This List

CytoSorbents chief medical officer retires; replacement named

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Blog

Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises


CytoSorbents chief medical officer retires; replacement named

Cytosorbents Corp. said its chief medical officer Robert Bartlett has retired from his post, but will stay with the company as a consultant and as co-chair of the cardiac surgery advisory board.

Eric Mortensen, who was previously vice president and therapeutic area clinical head for inflammation and immunology at Pfizer Inc., will replace Bartlett as chief medical officer.